Lab Information

Carolyn Jack (MD/PhD)

Scientist
Centre for Translational Biology
Department of Medicine (McGill)

Research Profile

 Fundamental: 50%
 Clinical: 40%
 Epidemiology: 0%
 Evaluation: 10%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Dermatology • Immunology • Atopic dermatitis • Immunophenotyping • T cell • Biomarkers

Team Members

Name Position

Latest Publications

  1. Asiniwasis, R., Merati, N., Roesler, J., Simpson, E. L., Aubry, R., McMullen, E., Fraess, L., Choi, U. Y., Hinther, K., Chu, D. K. & Jack, C. (2024). 'The Social and Home Environment: Impacts of Determinants of Health on Atopic Dermatitis, Pathways Towards Solutions, and Unique Considerations for Rural and Remote North American Indigenous Populations'. The journal of allergy and clinical immunology. In practice, vol. 12, p. 290-299.
  2. Zuberbier, T., Abdul Latiff, A., Aggelidis, X., Augustin, M., Balan, R.-G., Bangert, C., Beck, L., Bieber, T., Bernstein, J. A., Bertolin Colilla, M., Berardi, A., Bedbrook, A., Bindslev-Jensen, C., Bousquet, J., de Bruin-Weller, M., Bruscky, D., Buyuktiryaki, B., Canonica, G. W., Castro, C., Chanturidze, N., Chong-Neto, H. J., Chu, C.-Y., Chularojanamontri, L., Cork, M., Criado, R. F. J., Barredo, L. C., Custovic, A., Darsow, U., Emurlai, A., de Pablo, A., Del Giacco, S., Girolomoni, G., Deleva Jovanova, T., Deleuran, M., Douladiris, N., Duarte, B., Dubakiene, R., Eller, E., Engel-Yeger, B., Ensina, L. F., Filho, N. R., Flohr, C., Fomina, D., Francuzik, W., Galimberti, M. L., Giménez-Arnau, A. M., Godse, K., Mortz, C. G., Gotua, M., Hide, M., Hoetzenecker, W., Hunzelmann, N., Irvine, A., Jack, C., Kanavarou, I., Katoh, N., Kinaciyan, T., Kocatürk, E., Kulthanan, K., Lapeere, H., Lau, S., Machado Forti Nastri, M., Makris, M., Mansour, E., Marsland, A., Morelo Rocha Felix, M., Moschione Castro, A. P., Nettis, E., Nicolas, J. F., Nosbaum, A., Odemyr, M., Papapostolou, N., Parisi, C. A. S., Paudel, S., Peter, J., Pokharel, P., Puig, L., Quint, T., Ramon, G. D., Regateiro, F., Ricci, G., Rosario, C., Sackesen, C., Schmid-Grendelmeier, P., Serra-Baldrich, E., Siemens, K., Smith, C., Staubach, P., Stevanovic, K., Su-Kücük, Ö., Sussman, G., Tavecchio, S., Teovska Mitrevska, N., Thaci, D., Toubi, E., Traidl-Hoffmann, C., Treudler, R., Vadasz, Z., van Hofman, I., Ventura, M. T., Wang, Z., Werfel, T., Wollenberg, A., Yang, A., Weng Yew, Y., Zhao, Z., Zwiener, R. & Worm, M. (2023). A concept for integrated care pathways for atopic dermatitis-A GA2 LEN ADCARE initiative. Clinical and translational allergy, vol. 13, p. e12299.
  3. Chatrath, S., LeBovidge, J., Jack, C., Abuabara, K., Schneider, L. C., Capozza, K., Kelley, K. & Silverberg, J. I. (2023). Mental Health Interventions for Atopic Dermatitis: Knowledge Gaps, Pilot Programs, and Future Directions. Clinical and experimental dermatology, vol. 49, p. 9-17.
  4. Yeung, J., Gooderham, M. J., Hong, H.-C., Lynde, C., Prajapati, V. H., Lansang, P., Turchin, I., Wiseman, M., Jack, C., Ramien, M., Purdy, K. & Grewal, P. (2023). Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective. Journal of the American Academy of Dermatology, vol. 89, p. 372-375.
  5. Gimenez-Rivera, V.-A., Patel, H., Dupuy, F. P., Allakhverdi, Z., Bouchard, C., Madrenas, J., Bissonnette, R., Piccirillo, C. A. & Jack, C. (2023). NOD2 Agonism Counter-Regulates Human Type 2 T Cell Functions in Peripheral Blood Mononuclear Cell Cultures: Implications for Atopic Dermatitis. Biomolecules, vol. 13.
  6. Adam, D. N., Gooderham, M. J., Beecker, J. R., Hong, C. H., Jack, C. S., Jain, V., Lansang, P., Lynde, C. W., Papp, K. A., Prajapati, V. H., Turchin, I. & Yeung, J. (2023). Expert consensus on the systemic treatment of atopic dermatitis in special populations. Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 37, p. 1135-1148.
  7. Ghazal, S., Ridha, Z., D'Aguanno, K., Nassim, D., Quaiattini, A., Netchiporouk, E., Poulin, Y., Kalia, S., Marcoux, D., Piguet, V. & Jack, C. (2022). Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II. Frontiers in medicine, vol. 9, p. 821871.
  8. Papp, K. A., Hong, C.-H., Lansang, M. P., Turchin, I., Adam, D. N., Beecker, J. R., Bissonnette, R., Gooderham, M. J., Jack, C., Joseph, M., Lynde, C. W. & Shear, N. H. (2021). Practical Management of Patients with Atopic Dermatitis on Dupilumab. Dermatology and therapy, vol. 11, p. 1805-1828.
  9. Belmesk, L., Muntyanu, A., Cantin, E., AlHalees, Z., Jack, C. S., Le, M., Sasseville, D., Iannattone, L., Ben-Shoshan, M., Litvinov, I. V. & Netchiporouk, E. (2022). Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis. Journal of cutaneous medicine and surgery, vol. 26, p. 33-49.
  10. Maintz, L., Bieber, T., Bissonnette, R. & Jack, C. (2021). Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical Care. The journal of allergy and clinical immunology. In practice, vol. 9, p. 1473-1486.e2.
More on PubMed 



See also

Card image
Elena
Netchiporouk


See profile
Card image
Ciriaco
Piccirillo


See profile
Card image
Moshe
Ben-Shoshan


See profile